$3.99
ImmuCell Corporation is a biotechnology business based in the US. ImmuCell Corporation shares (ICCC) are listed on the NASDAQ and all prices are listed in US Dollars. ImmuCell Corporation employs 75 staff and has a trailing 12-month revenue of around $23.2 million.
Our top picks for where to buy ImmuCell Corporation stock
How to buy ImmuCell Corporation stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ICCC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy ImmuCell Corporation stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
ImmuCell Corporation stock price (NASDAQ: ICCC)
Use our graph to track the performance of ICCC stocks over time.ImmuCell Corporation shares at a glance
Latest market close | $3.99 |
---|---|
52-week range | $3.50 - $5.64 |
50-day moving average | $4.05 |
200-day moving average | $4.71 |
Wall St. target price | $14.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.52 |
Is it a good time to buy ImmuCell Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ImmuCell Corporation price performance over time
Historical closes compared with the close of $3.99 from 2024-09-06
1 week (2024-08-30) | 6.68% |
---|---|
1 month (2024-08-07) | 6.40% |
3 months (2024-06-07) | -11.14% |
6 months (2024-03-07) | -23.27% |
1 year (2023-09-07) | -14.01% |
---|---|
2 years (2022-09-07) | -47.08% |
3 years (2021-09-07) | 8.88 |
5 years (2019-09-06) | 5.15 |
ImmuCell Corporation financials
Revenue TTM | $23.2 million |
---|---|
Gross profit TTM | $7.6 billion |
Return on assets TTM | -4.87% |
Return on equity TTM | -16.1% |
Profit margin | -17.44% |
Book value | $2.99 |
Market Capitalization | $29.3 million |
TTM: trailing 12 months
ImmuCell Corporation share dividends
We're not expecting ImmuCell Corporation to pay a dividend over the next 12 months.
Have ImmuCell Corporation's shares ever split?
ImmuCell Corporation's shares were split on a 1:100 basis on 24 July 1990. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ImmuCell Corporation shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for ImmuCell Corporation shares which in turn could have impacted ImmuCell Corporation's share price.
ImmuCell Corporation share price volatility
Over the last 12 months, ImmuCell Corporation's shares have ranged in value from as little as $3.5 up to $5.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmuCell Corporation's is 0.588. This would suggest that ImmuCell Corporation's shares are less volatile than average (for this exchange).
ImmuCell Corporation overview
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.
Frequently asked questions
nullWhat percentage of ImmuCell Corporation is owned by insiders or institutions?
Currently 38.135% of ImmuCell Corporation shares are held by insiders and 14.701% by institutions. How many people work for ImmuCell Corporation?
Latest data suggests 75 work at ImmuCell Corporation. When does the fiscal year end for ImmuCell Corporation?
ImmuCell Corporation's fiscal year ends in December. Where is ImmuCell Corporation based?
ImmuCell Corporation's address is: 56 Evergreen Drive, Portland, ME, United States, 04103 What is ImmuCell Corporation's ISIN number?
ImmuCell Corporation's international securities identification number is: US4525253062 What is ImmuCell Corporation's CUSIP number?
ImmuCell Corporation's Committee on Uniform Securities Identification Procedures number is: 452525306
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question